ReviewEndocrinology2026
Primary cilia as platforms for islet neurotransmitter signaling.
Review in Endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Pancreatic islets maintain glucose homeostasis through the coordinated secretion of hormones and, notably, neurotransmitters. While islet innervation has long been recognized as essential for development and function, the source of these neuromodulators is variable and so is their signaling. Islet α and β cells express a broad repertoire of receptors for neurotransmitters such as acetylcholine, glutamate, GABA, and catecholamines. Emerging evidence reveals an additional layer of regulatory complexity, as a subset of these receptors localize to the primary cilium, a sensory organelle that functions as a specialized signaling hub. Disruption of primary cilia on β cells impairs glucose homeostasis in mice, and human ciliopathies commonly feature metabolic dysfunction. In this review, we synthesize recent findings on neurotransmitter signaling within the islet, with a focus on pathways that converge on the primary cilium. We discuss how compartmentalized signaling via cilia-enriched receptors represents a new dimension of islet cell regulation and offer a perspective on how targeting these ciliary pathways may provide future research directions for modulating α- and β-cell function in diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.